APA (7th ed.) Citation

Yang, H., Wei, Y., Deng, P., Ou, H., Nie, H., & Zhuang, Y. (2022). Feasibility and safety of minimally invasive technology for interval cytoreductive surgery during advanced ovarian cancer after neoadjuvant chemotherapy. European Journal of Gynaecological Oncology, 43(6), 4. https://doi.org/10.22514/ejgo.2022.052

Chicago Style (17th ed.) Citation

Yang, Hua, Yutao Wei, Panxia Deng, Honghui Ou, Huilong Nie, and Yuan Zhuang. "Feasibility and Safety of Minimally Invasive Technology for Interval Cytoreductive Surgery During Advanced Ovarian Cancer After Neoadjuvant Chemotherapy." European Journal of Gynaecological Oncology 43, no. 6 (2022): 4. https://doi.org/10.22514/ejgo.2022.052.

MLA (9th ed.) Citation

Yang, Hua, et al. "Feasibility and Safety of Minimally Invasive Technology for Interval Cytoreductive Surgery During Advanced Ovarian Cancer After Neoadjuvant Chemotherapy." European Journal of Gynaecological Oncology, vol. 43, no. 6, 2022, p. 4, https://doi.org/10.22514/ejgo.2022.052.